The global bioreactors market is expected to reach to USD 1,417 Million by 2021, at a CAGR of 6.8% between 2016 and 2021. The increase in adoption of single-use technologies, use of hybrid technologies: single-use and stainless steel, growing popularity of single-use bioreactor among biopharmaceutical companies, and growing biologics are spurring the growth of the bioreactors market. However, regulatory concerns related to single-use bioreactors, issues regarding leachable and extractable related to single-use bags is hampering the growth of this market.
The global bioreactor market is segmented on the basis of end-users, usage, scale, material, control types and suppliers. Furthermore, the geographic analysis covers North America, Europe, Asia-Pacific, and Rest of the World (RoW).
On the basis of end-user, the bioreactor market has been segmented into R&D departments and biopharmaceutical manufacturers. The R&D departments segment is expected to register the highest growth rate from 2016 to 2021 owing to increased bioreactor usage in process development. Contract manufacturing organizations (CMOs) on the other hand are expected to gain traction in the coming years due to rise in outsourcing needs for biologics manufacturers as a result of increased demand of biologics.
The North American region accounted for the largest share in the bioreactors market in 2016. One of the main factors contributing to this large share is the increase in number of biomanufacturing facilities and investments in this region. Government in North American countries actively supports the biologics production by providing funds to life science R&D.
The bioreactors market is a competitive market with a large number of companies operational in the market. The competitive landscape includes an in-depth market share analysis along with the key business strengths of leading players in the market. Some of the leading players offering bioreactor products are Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), GE Healthcare (A subsidiary of General Electric Company) (U.S.), Danaher Corporation (U.S), Eppendorf AG (Germany).
Comments
Post a Comment